Home BiOneCure Therapeutics

BiOneCure Therapeutics

In operation
-
Innovative ADC Drug Developer
Basic
Enterprise Profile

Basic Information

BiOneCure Therapeutics, Inc. (BiOneCure) is a clinical-stage biopharmaceutical company dedicated to developing innovative ADC drugs for cancer treatment. The company is led by industry veterans from Pfizer, AstraZeneca, Amgen, and other similar companies, with successful experience in drug discovery and development in the ADC field. The company has developed a proprietary payload platform that provides a tailored approach for ADC drug development.
BiOneCure Therapeutics, Inc.
Maryland,United States of America
unclear
January 01, 2017
info@bionecure.com

Enterprise Profile

Industrial Sector
New Drug Development
Concept
Tumor Therapeutic Products
Application Scenarios
Innovative Drugs ADC (Antibody-Drug Conjugate)